Gastroenterology and Hepatology - Global Oncology Academy

49-64 of 83

Bridging Gaps with Blood-Based CRC Screening
Bridging Gaps with Blood-Based CRC Screening
On the Frontlines of Colorectal Cancer
Bridging Gaps with Blood-Based CRC Screening
Ryan Quigley; Aasma Shaukat, MD, MPH
- Ryan Quigley
- Aasma Shaukat, MD, MPH
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
On the Frontlines of Colorectal Cancer
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Ryan Quigley; Thomas Cataldo, MD
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Prioritizing Quality of Life in CRC: Key Surgical Considerations
On the Frontlines of Colorectal Cancer
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Ryan Quigley; Thomas Cataldo, MD
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
Advancing HER2-Targeted Therapy in GI Cancers
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®
Advancing HER2-Targeted Therapy in GI Cancers
John H. Strickler, MD
- John H. Strickler, MD
How AI Is Transforming Biomarker Development in GI Oncology
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®
How AI Is Transforming Biomarker Development in GI Oncology
William Hall, MD
- William Hall, MD
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Project Oncology®
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Daniela Molena, MD
- Daniela Molena, MD
The Metabolic Roots of Early-Onset Colorectal Cancer
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®
The Metabolic Roots of Early-Onset Colorectal Cancer
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Project Oncology®
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
GI Insights
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Peter Buch, MD, FACG, AGAF, FACP; Aasma Shaukat, MD, MPH
- Peter Buch, MD, FACG, AGAF, FACP
- Aasma Shaukat, MD, MPH
Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Project Oncology®
Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Jennifer Caudle, DO, FACOFP; Samuel Klempner, MD
- Jennifer Caudle, DO, FACOFP
- Samuel Klempner, MD
- Nataliya Uboha, MD, PhD
MinuteCE®
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making  
James M. Cleary, MD, PhD
0.50 credits 4 episodes
- James M. Cleary, MD, PhD
0.50 credits 4 episodes
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Ryan Quigley; Hallie Blevins, PhD
- Ryan Quigley
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Project Oncology®
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Namrata Vijayvergia, MD
- Namrata Vijayvergia, MD
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
Project Oncology®
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
Namrata Vijayvergia, MD
- Namrata Vijayvergia, MD
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Project Oncology®
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target

4/6